Cargando…
Curcumin Nanoparticle Enhances the Anticancer Effect of Cisplatin by Inhibiting PI3K/AKT and JAK/STAT3 Pathway in Rat Ovarian Carcinoma Induced by DMBA
Cisplatin has been used for decades for the treatment of ovarian cancer. However, despite its potent anticancer effect, cisplatin’s efficacy as a single agent was inadequate in patients with advanced stage. Curcumin has been shown to sensitize cisplatin activity in several cancer models. However, th...
Autores principales: | Sandhiutami, Ni Made Dwi, Arozal, Wawaimuli, Louisa, Melva, Rahmat, Deni, Wuyung, Puspita Eka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7848208/ https://www.ncbi.nlm.nih.gov/pubmed/33536913 http://dx.doi.org/10.3389/fphar.2020.603235 |
Ejemplares similares
-
Comparative Effect of Curcumin and Nanocurcumin on Nephroprotection at Cisplatin-induced Rats
por: Sandhiutami, Ni Made D., et al.
Publicado: (2019) -
Development, Characterization and Pharmacokinetic Profile of Chitosan-Sodium Tripolyphosphate Nanoparticles Based Drug Delivery Systems for Curcumin
por: Arozal, Wawaimuli, et al.
Publicado: (2021) -
Nanocurcumin preserves kidney function and haematology parameters in DMBA-induced ovarian cancer treated with cisplatin via its antioxidative and anti-inflammatory effect in rats
por: Louisa, Melva, et al.
Publicado: (2023) -
Curcumin Prevents Epithelial-to Mesenchymal Transition-Mediated Ovarian Cancer Progression through NRF2/ETBR/ET-1 Axis and Preserves Mitochondria Biogenesis in Kidney after Cisplatin Administration
por: Barinda, Agian Jeffilano, et al.
Publicado: (2022) -
Selected Indonesian Medicinal Plants for the Management of Metabolic Syndrome: Molecular Basis and Recent Studies
por: Arozal, Wawaimuli, et al.
Publicado: (2020)